Sunshine at the European regulator.
作者信息
Sukkar Elizabeth
出版信息
BMJ. 2012 Feb 15;344:e976. doi: 10.1136/bmj.e976.
DOI:10.1136/bmj.e976
PMID:22337754
Abstract
摘要
相似文献
1
Sunshine at the European regulator.
BMJ. 2012 Feb 15;344:e976. doi: 10.1136/bmj.e976.
2
European medicines agency: riddled with conflicts of interest.欧洲药品管理局：充斥着利益冲突。
Prescrire Int. 2012 Nov;21(132):278.
3
The first 2 years of the European Medicines Agency's policy on access to documents: secret no longer.欧洲药品管理局文件获取政策的头两年：不再保密。
JAMA Intern Med. 2013 Mar 11;173(5):380-2. doi: 10.1001/jamainternmed.2013.3838.
4
On the prohibition of conflicts of interest in pharmaceutical regulation: precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O'Donovan and Lexchin.论药品监管中利益冲突的禁止：预防性限制与许可性挑战。对西斯蒙多（《科学史与科学哲学研究》66:9，2008，1909 - 1914）以及奥多诺万和莱克辛的评论
Soc Sci Med. 2010 Mar;70(5):648-51. doi: 10.1016/j.socscimed.2009.09.059. Epub 2009 Dec 26.
5
The innovative medicines initiative: a European response to the innovation challenge.创新药物倡议：欧洲对创新挑战的回应。
Clin Pharmacol Ther. 2012 Mar;91(3):418-25. doi: 10.1038/clpt.2011.321. Epub 2012 Feb 8.
6
New law introduces tougher rules on drug regulation in France.新法律对法国的药品监管引入了更严格的规定。
BMJ. 2011 Dec 22;343:d8309. doi: 10.1136/bmj.d8309.
7
Second BC drug safety scientist reinstated.第二名英国药品安全科学家复职。
CMAJ. 2014 Sep 2;186(12):E443. doi: 10.1503/cmaj.109-4860. Epub 2014 Jul 28.
8
Medicines agencies too often under the influence of drug companies.药品监管机构常常受到制药公司的影响。
Prescrire Int. 2011 Apr;20(115):108.
9
Prohibiting or 'managing' conflict of interest? A review of policies and procedures in three European drug regulation agencies.禁止还是“管理”利益冲突？对三个欧洲药品监管机构的政策和程序的审查。
Soc Sci Med. 2010 Mar;70(5):643-7. doi: 10.1016/j.socscimed.2009.09.002. Epub 2009 Sep 24.
10
Optometry and the drug enforcement administration.验光与药品执法管理局
J Am Optom Assoc. 1981 Jun;52(6):495-8.
Zotero 插件